U.S. Markets closed

Unisys Corporation (UIS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.05-0.35 (-2.82%)
At close: 4:02PM EDT
People also watch
Interactive chart
Previous Close12.40
Bid0.00 x
Ask0.00 x
Day's Range11.85 - 12.40
52 Week Range6.72 - 16.70
Avg. Volume874,109
Market Cap607.4M
PE Ratio (TTM)-14.91
EPS (TTM)-0.81
Earnings DateJul 24, 2017 - Jul 28, 2017
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1990-06-18
1y Target Est16.25
Trade prices are not sourced from all markets
  • Capital Cube12 hours ago

    ETFs with exposure to Unisys Corp. : May 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Unisys Corp. Here are 5 ETFs with the largest exposure to UIS-US. Comparing the performance and risk of Unisys Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Unisys (UIS) Up 1.7% Since Earnings Report: Can It Continue?
    Zacks2 days ago

    Unisys (UIS) Up 1.7% Since Earnings Report: Can It Continue?

    Unisys (UIS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • PR Newswire4 days ago

    Unisys Launches ActiveInsights™ PharmaTrack to Provide Enhanced Visibility and Management of the Entire Pharmaceutical Supply Chain

    BLUE BELL, Pa., May 23, 2017 /PRNewswire/ -- Unisys Corporation (UIS) today launched PharmaTrack, new software that combines leading security, advanced data analytics and compliance technology in a single, unified platform to provide life sciences and healthcare companies enhanced visibility and oversight of the entire global pharmaceutical supply chain and thus help combat theft and counterfeit drugs. This newest addition to the Unisys ActiveInsights™ suite of solutions arose from an overlap of industry needs between two industries in which Unisys has deep domain expertise: life sciences and healthcare, and travel and transportation. "When we starting talking to people involved in pharmaceutical supply chain management, we quickly realized that Unisys already had developed the technologies in other industries required to address longstanding problems in pharmaceuticals," said Jeff R. Livingstone, PhD, vice president and global head, Life Sciences and Healthcare, Unisys.